Cytoplasmic EGFR interacted with SIK2 blocking the activation of LATS1 and MST1 and promoting YAP nuclear translocation in first-generation TKI resistance NSCLC cells 51. The gene discussed is SIK2; the disease is non-small cell lung carcinoma.